Erratum

Professor Schmiegel, Dr. Pox, and Professor Rödel, three of the authors of the clinical practice guideline “Colorectal Carcinoma,” which appeared in Deutsches Ärzteblatt International on 21 December 2009 (issue 51–52), have corrected their Conflict of Interest Statement, as follows:

Professor Schmiegel has received lecture honoraria from the Merck, Roche, Abbott, Amgen, Astra-Zeneca, Pfizer, and Falk companies. He has also received reimbursement of travel expenses from the Roche, Merck, and Astra-Zeneca companies and has served as a paid consultant to the Roche, Amgen, and Astra-Zeneca companies.

Dr. Pox has received lecture honoraria from the Falk, Astra-Zeneca, and Hitachi companies and reimbursement of travel expenses from Roche.

Professor Rödel has received lecture honoraria from the Roche and Sanofi-Aventis companies and support for research projects from Merck.